63 related articles for article (PubMed ID: 1316782)
41. Immunodominant structures in the aminoterminal portion of human interferon alpha 1.
Kontsek P; Borecký L; Kontseková E; Kolcunová A; Novák M; Zav'yalov VP; Maiorov VA
Mol Immunol; 1992; 29(7-8):863-70. PubMed ID: 1378930
[TBL] [Abstract][Full Text] [Related]
42. Characterization of interferon-alpha binding sites on human cell lines.
Vanden Broecke C; Pfeffer LM
J Interferon Res; 1988 Dec; 8(6):803-11. PubMed ID: 2466092
[TBL] [Abstract][Full Text] [Related]
43. Identification of interferon receptors by chemical cross-linking.
Gupta SL; Raziuddin A
Methods Enzymol; 1986; 119():340-7. PubMed ID: 2429150
[No Abstract] [Full Text] [Related]
44. Expression of type I interferon receptor in solid tumors of childhood.
Rosolen A; Todesco A; Colamonici OR; Basso G; Frascella E
Mod Pathol; 1997 Jan; 10(1):55-61. PubMed ID: 9021727
[TBL] [Abstract][Full Text] [Related]
45. Multichain structure of the IFN-alpha receptor on hematopoietic cells.
Colamonici OR; Pfeffer LM; D'Alessandro F; Platanias LC; Gregory SA; Rosolen A; Nordan R; Cruciani RA; Diaz MO
J Immunol; 1992 Apr; 148(7):2126-32. PubMed ID: 1531999
[TBL] [Abstract][Full Text] [Related]
46. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
[TBL] [Abstract][Full Text] [Related]
47. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.
Yano H; Iemura A; Haramaki M; Ogasawara S; Takayama A; Akiba J; Kojiro M
Hepatology; 1999 Jun; 29(6):1708-17. PubMed ID: 10347112
[TBL] [Abstract][Full Text] [Related]
48. Interferon-gamma inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells.
Martin DM; Carlson RO; Feldman EL
J Neurosci Res; 1993 Apr; 34(5):489-501. PubMed ID: 8478984
[TBL] [Abstract][Full Text] [Related]
49. Detection of functional interferon alpha receptors in human neuroendocrine tumor cell lines using a new monoclonal antibody.
Rosolen A; Colamonici OR; Pfeffer LM; Whitesell L; Nordan R; Neckers LM
Eur Cytokine Netw; 1992; 3(2):81-8. PubMed ID: 1316782
[TBL] [Abstract][Full Text] [Related]
50. Biologic activities of natural and synthetic type I interferons.
Pfeffer LM
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat.
Saphier D; Roerig SC; Ito C; Vlasak WR; Farrar GE; Broyles JE; Welch JE
Brain Behav Immun; 1994 Mar; 8(1):37-56. PubMed ID: 8003770
[TBL] [Abstract][Full Text] [Related]
52. Structure of the human interferon alpha receptor.
Colamonici OR; Pfeffer LM
Pharmacol Ther; 1991 Nov; 52(2):227-33. PubMed ID: 1726335
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
